Psoriasis trials in Taiwan

1 of 6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  Where

  New Taipei City, Taichung, Taipei

  Age

  18 years to 75 years

  People

  1,200 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06764693